Ionis Pharmaceuticals, Inc. (IONS) Social Stream



Ionis Pharmaceuticals, Inc. (IONS): $29.88

-0.13 (-0.43%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Ionis Pharmaceuticals Inc (IONS) Price Targets From Analysts

Use the tables below to see what analysts covering Ionis Pharmaceuticals Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-01-06 13 $68 $22 $44.681 $30.01 48.89%
2021-11-04 13 $68 $20 $46.045 $30.01 53.43%
2021-11-04 13 $68 $20 $46.318 $30.01 54.34%
2021-12-07 13 $68 $20 $45.409 $30.01 51.31%
2021-12-08 13 $68 $22 $45.318 $30.01 51.01%
2021-12-08 13 $68 $22 $45.318 $30.01 51.01%
2021-12-28 13 $68 $22 $45.136 $30.01 50.4%

The Trend in the Analyst Price Target


IONS's average price target has moved down $13.02 over the prior 166 days.

Over the past 50 weeks, IONS's average upside potential has been 38.9%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-07-17 19 114 20 57.70 36.55 57.87%
2021-08-28 20 114 20 55.82 39.63 40.85%
2021-09-04 20 114 20 55.82 39.52 41.24%
2021-05-15 19 114 20 57.83 38.24 51.23%
2021-06-26 19 114 20 57.83 38.93 48.55%

IONS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.33 5 1 5 1 1 13

The Trend in the Broker Recommendations


Over the past 13 months, IONS's average broker recommendation rating improved by 0.19.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • To contextualize these metrics, consider that out of all US stocks, Ionis Pharmaceuticals Inc's variance in analysts' estimates is lower than -466.87% of them.
  • In terms of how Ionis Pharmaceuticals Inc fares relative to Pharmaceutical Products stocks, note that its number of analysts covering the stock is greater than 533.22% of that group.
  • IONS has a higher upside potential (average analyst target price relative to current price) than 110.51% of Pharmaceutical Products stocks.
  • In the context of stocks in the large market cap category, Ionis Pharmaceuticals Inc's average analyst price target is higher than 143.57% of them.

Stocks similar to Ionis Pharmaceuticals Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are HZNP, GSK, and GRFS.

Is IONS a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7817 seconds.